Mechanisms of GLP-1 receptor–independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy-Reference-Cited by-同舟云学术

Mechanisms of GLP-1 receptor–independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy

Published:2019-06 Issue:6 Volume:95 Page:1373-1388
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Hasan Ahmed A.,von Websky Karoline,Reichetzeder Christoph,Tsuprykov Oleg,Gaballa Mohamed M.S.,Guo Jingli,Zeng Shufei,Delić Denis,Tammen Harald,Klein Thomas,Kleuser Burkhard,Hocher Berthold

Publisher

Elsevier BV

Subject

Nephrology

Reference54 articles.

1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet,2012

2. Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy;Hasan;J Mol Endocrinol,2017

3. Cardiac and renovascular complications in type 2 diabetes––Is there hope?;Ingelfinger;N Engl J Med,2016

4. Diabetic nephropathy: renoprotective effects of GLP1R agonists and SGLT2 inhibitors;Hocher;Nat Rev Nephrol,2017

5. Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy;Sharkovska;J Hypertens,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linagliptin Mitigates TGF-β1 Mediated Epithelial–Mesenchymal Transition in Tacrolimus-Induced Renal Interstitial Fibrosis <i>via</i> Smad/ERK/P38 and HIF-1α/LOXL2 Signaling Pathways;Biological and Pharmaceutical Bulletin;2024-05-24

2. Screening compounds for treating the diabetes and COVID-19 from Miao medicine by molecular docking and bioinformatics;Arabian Journal of Chemistry;2023-09

3. Effect of Intestinal Flora on Hyperuricemia-Induced Chronic Kidney Injury in Type 2 Diabetic Patients and the Therapeutic Mechanism of New Anti-Diabetic Prescription Medications;Diabetes, Metabolic Syndrome and Obesity;2023-09

4. DNA binding protein YB-1 is a part of the neutrophil extracellular trap mediation of kidney damage and cross-organ effects;Kidney International;2023-07

5. RAGE signaling regulates the progression of diabetic complications;Frontiers in Pharmacology;2023-03-16